PortfoliosLab logoPortfoliosLab logo
EME vs. ANAB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EME vs. ANAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in EMCOR Group, Inc. (EME) and AnaptysBio, Inc. (ANAB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EME achieves a 36.89% return, which is significantly lower than ANAB's 77.94% return.


EME

1D
1.10%
1M
-1.45%
YTD
36.89%
6M
36.98%
1Y
72.81%
3Y*
68.65%
5Y*
48.34%
10Y*
33.87%

ANAB

1D
1.30%
1M
-3.68%
YTD
77.94%
6M
75.76%
1Y
272.31%
3Y*
66.32%
5Y*
28.81%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

EME vs. ANAB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EME
EMCOR Group, Inc.
36.89%35.05%111.27%46.03%16.81%39.93%6.47%45.18%-26.68%15.75%
ANAB
AnaptysBio, Inc.
77.94%266.16%-38.19%-30.88%-10.82%61.63%32.31%-74.53%-36.67%529.50%

Correlation

The correlation between EME and ANAB is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jan 26, 2017

0.20

Fundamentals

Market Cap

EME:

$37.69B

ANAB:

$1.65B

EPS

EME:

$29.65

ANAB:

-$0.91

PS Ratio

EME:

2.12

ANAB:

7.29

PB Ratio

EME:

9.75

ANAB:

129.44

Total Revenue (TTM)

EME:

$17.75B

ANAB:

$232.39M

Gross Profit (TTM)

EME:

$3.47B

ANAB:

$245.59M

EBITDA (TTM)

EME:

$2.03B

ANAB:

$52.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EME vs. ANAB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EME
EME Risk / Return Rank: 8484
Overall Rank
EME Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
EME Sortino Ratio Rank: 8181
Sortino Ratio Rank
EME Omega Ratio Rank: 8585
Omega Ratio Rank
EME Calmar Ratio Rank: 8383
Calmar Ratio Rank
EME Martin Ratio Rank: 8282
Martin Ratio Rank

ANAB
ANAB Risk / Return Rank: 9696
Overall Rank
ANAB Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
ANAB Sortino Ratio Rank: 9595
Sortino Ratio Rank
ANAB Omega Ratio Rank: 9595
Omega Ratio Rank
ANAB Calmar Ratio Rank: 9797
Calmar Ratio Rank
ANAB Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EME vs. ANAB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for EMCOR Group, Inc. (EME) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EMEANABDifference
Sharpe ratioReturn per unit of total volatility

-2.03

Sortino ratioReturn per unit of downside risk

-1.74

Omega ratioGain probability vs. loss probability

1.34

1.54

-0.20

Calmar ratioReturn relative to maximum drawdown

2.91

9.62

-6.71

Martin ratioReturn relative to average drawdown

7.10

22.85

-15.75

EME vs. ANAB - Sharpe Ratio Comparison

The current EME Sharpe Ratio is 1.89, which is lower than the ANAB Sharpe Ratio of 3.92. The chart below compares the historical Sharpe Ratios of EME and ANAB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EME vs. ANAB - Drawdown Comparison

The maximum EME drawdown since its inception was -70.56%, smaller than the maximum ANAB drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for EME and ANAB.


Loading charts...

Drawdown Indicators


EMEANABDifference

Max Drawdown

Largest peak-to-trough decline

-70.56%

-92.08%

+21.52%

Max Drawdown (1Y)

Largest decline over 1 year

-25.15%

-28.15%

+3.00%

Max Drawdown (3Y)

Largest decline over 3 years

-36.19%

-69.32%

+33.13%

Max Drawdown (5Y)

Largest decline over 5 years

-36.19%

-69.32%

+33.13%

Max Drawdown (10Y)

Largest decline over 10 years

-48.00%

Current Drawdown

Current decline from peak

-11.35%

-32.89%

+21.54%

Average Drawdown

Average peak-to-trough decline

-15.36%

-64.58%

+49.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.28%

11.83%

-1.55%

Volatility

EME vs. ANAB - Volatility Comparison

The current volatility for EMCOR Group, Inc. (EME) is 9.99%, while AnaptysBio, Inc. (ANAB) has a volatility of 12.25%. This indicates that EME experiences smaller price fluctuations and is considered to be less risky than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EMEANABDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.99%

12.25%

-2.26%

Volatility (6M)

Calculated over the trailing 6-month period

26.49%

46.71%

-20.22%

Volatility (1Y)

Calculated over the trailing 1-year period

38.67%

69.09%

-30.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.40%

65.38%

-31.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.05%

75.41%

-42.36%

Dividends

EME vs. ANAB - Dividend Comparison

EME's dividend yield for the trailing twelve months is around 0.16%, while ANAB has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ANAB
AnaptysBio, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EME
EMCOR Group, Inc.
0.16%0.16%0.20%0.32%0.36%0.41%0.35%0.37%0.54%0.39%0.45%0.67%

Financials

EME vs. ANAB - Financials Comparison

This section allows you to compare key financial metrics between EMCOR Group, Inc. and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20222023202420252026
4.63B
25.56M
(EME) Total Revenue
(ANAB) Total Revenue
Values in USD except per share items

Frequently Asked Questions


EME and ANAB have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ANAB has higher volatility (12.25%) compared to EME (9.99%). In terms of maximum drawdown, EME dropped -70.56% vs ANAB's -92.08%.

ANAB currently has the higher Sharpe Ratio (3.92 vs 1.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EME and ANAB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer